US FDA approves phase 3 trial for new biological drug

Apimeds Inc., a local biopharmaceutical company, said it has received approval from the U.S. Food and Drug Administration to conduct Phase III clinical trial of a drug for the treatment of autoimmune disease and pain relief in chronic arthritis.

Company officials said the approval comes after successful completion of animal, pre-clinical and clinical trials on Apitox, which is classified int...